• Advertise
  • Contact Us
  • Write For Us
  • Our Team
Extraction Magazine
No Result
View All Result
  • Botanical Extraction
    • Cannabinoids
    • Psychedelics
    • Nutraceutical
    • Product Refinement
  • Industry News
    • Business
    • Sustainability
    • Safety & Compliance
    • Partners
  • Extraction Technology
    • Equipment
    • Methods
    • Solvents
    • DIY Extraction
    • Analytical Techniques
  • Medical Research
  • Glossary
  • Business Directory
  • Botanical Extraction
    • Cannabinoids
    • Psychedelics
    • Nutraceutical
    • Product Refinement
  • Industry News
    • Business
    • Sustainability
    • Safety & Compliance
    • Partners
  • Extraction Technology
    • Equipment
    • Methods
    • Solvents
    • DIY Extraction
    • Analytical Techniques
  • Medical Research
  • Glossary
  • Business Directory
No Result
View All Result
Extraction Magazine
No Result
View All Result
Home Industry News

Study: Adult Use Retail Customers Frequently Substitute Cannabis for Opioids, Other Prescription Drugs

Shared Content by Shared Content
July 24, 2019
in Industry News
Study: Adult Use Retail Customers Frequently Substitute Cannabis for Opioids, Other Prescription Drugs

Adults who purchase retail cannabis typically report using it to mitigate pain and to improve sleep, and often use it in place of conventional medications, according to data published online today in the Journal of Psychoactive Drugs.

A team of investigators from the Albert Einstein College of Medicine in New York and the University of Miami assessed cannabis use trends among 1,000 adult use customers in Colorado.

READ ALSO

What Is Winterization? Lessons From Food and Pharma for Extraction Operators

FECO vs RSO: What Extraction Operators Can Learn From Food and Supplement Manufacturing

Seventy-four percent of those surveyed said that they consumed cannabis to promote sleep, while 65 percent reported using cannabis to alleviate pain. Among those respondents with a history of taking prescription sleep aids, 83 percent reported either reducing or ceasing their use of those medicines. Among those respondents with a history of consuming prescription opioids, 88 percent reported mitigating or stopping their use.

“Our findings suggest that de facto medical use may be highly prevalent among adult use customers, and that access to an adult use cannabis market may influence individuals’ use of other medications,” authors concluded. “Our findings … suggest that adult use customers may be similar to medical cannabis patients in their use of cannabis as a substitute for prescription analgesics and sleep aids. … While adult use laws are frequently called ‘recreational,’ … our findings suggest that many customers use cannabis for symptom relief.”

NORML Deputy Director Paul Armentano said that the study’s findings are significant, though not altogether surprising. “Several prior studies similarly show that the use of cannabis by qualified patients is associated with the reduction, or even the elimination, of certain other prescription drugs — specifically opioids — over time,” he said. “These findings speak not only to the therapeutic efficacy of cannabis as an alternative analgesic option, but also to its potential role as a harm reduction agent.”

Longitudinal studies assessing the use of prescription drugs following patients’ enrollment in state-sanctioned medical cannabis access programs frequently report a decline in the use of conventional medicines, specifically opioids, anti-anxiety drugs, and sleep aids.

The abstract of the study, “Use of cannabis to relieve pain and promote sleep by customers at an adult use dispensary,” appears online here.

###

NORML’s mission is to move public opinion sufficiently to legalize the responsible use of cannabis by adults, and to serve as an advocate for consumers to assure they have access to high-quality cannabis that is safe, convenient, and affordable.

Find out more at www.norml.org and read our factsheets on the most common misconceptions and myths regarding reform efforts around the country at www.norml.org/marijuana/fact-sheets

Related Posts

Botanical Extraction

What Is Winterization? Lessons From Food and Pharma for Extraction Operators

November 21, 2026
Botanical Extraction

FECO vs RSO: What Extraction Operators Can Learn From Food and Supplement Manufacturing

November 19, 2026
Botanical Extraction

Solventless Extraction Methods Explained: What Food and Supplement Manufacturing Can Teach Operators

November 18, 2026
Botanical Extraction

What Is Full Spectrum Extract? Lessons From Food, Pharma and Supplements for Extraction Operators

November 18, 2026
Botanical Extraction

Live Resin vs Live Sugar vs Live Rosin: What Food and Pharma Quality Systems Teach Extractors

November 16, 2026
Botanical Extraction

Top 10 Plants Used for Hydrosol Production, and the Quality Lessons Each One Teaches

November 15, 2026
Next Post
Results from recent study reveal that the polarization process increases COX 2 Inhibition by 572%

Results from recent study reveal that the polarization process increases COX 2 Inhibition by 572%

Sitemap

© 2026 Extraction Magazine is the trusted provider of botanical extraction news and the leading media in the ever-changing extraction industry.

No Result
View All Result
  • Industry News
  • Botanical Extraction
  • Medical Research
  • Medical Research
  • Glossary
  • Our Team
  • Write For Us

© 2026 Extraction Magazine is the trusted provider of botanical extraction news and the leading media in the ever-changing extraction industry.